MNST:NASDAQMonster Beverage Corporation Analysis
Data as of 2026-03-10 - not real-time
$75.73
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Monster Beverage is trading just above its 20‑day SMA (~81.5) and 50‑day SMA (~80.1), with the 200‑day SMA (~69.5) well below, confirming a bullish long‑term trend despite a short‑term pullback. The stock sits near the identified support level of $73.35 and the RSI of 32 signals oversold conditions, while the MACD has turned bearish, suggesting a potential rebound zone. Revenue growth of 17.6% and operating margins near 30% underscore strong fundamentals, and the company’s cash pile ($2.8 bn) comfortably exceeds its modest debt load. However, the DCF fair‑value estimate of $46.45 is far below the current price of $75.73, indicating that valuation metrics are stretched. Analyst sentiment remains upbeat, with a consensus “Buy” and a median price target of $90, while the Fear & Greed Index shows “Extreme Greed,” reflecting heightened market optimism. Overall, the blend of solid earnings momentum, low beta (≈0.34), and rising volume supports a cautious entry point.
Risks include the elevated valuation multiples (PE ~39) and a bearish MACD histogram, which could lead to short‑term volatility. The company’s diversification into alcohol and hard seltzer brands adds growth upside, but regulatory scrutiny on beverage ingredients and sugar content remains a medium‑term concern. Given the defensive consumer sector positioning and strong cash generation, the stock appears positioned for a measured upside, though investors should monitor price action around the support zone and any earnings surprises.
Risks include the elevated valuation multiples (PE ~39) and a bearish MACD histogram, which could lead to short‑term volatility. The company’s diversification into alcohol and hard seltzer brands adds growth upside, but regulatory scrutiny on beverage ingredients and sugar content remains a medium‑term concern. Given the defensive consumer sector positioning and strong cash generation, the stock appears positioned for a measured upside, though investors should monitor price action around the support zone and any earnings surprises.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near technical support with oversold RSI
- Increasing volume indicating buying interest
- Strong cash position providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust revenue growth and high operating margins
- Analyst consensus buy and median target of $90
- Diversification into alcohol and hard‑seltzer segments
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Defensive consumer sector exposure
- Low beta and solid balance sheet
- Potential valuation compression versus DCF fair value
Key Metrics & Analysis
Financial Health
Revenue Growth17.60%
Profit Margin22.97%
P/E Ratio39.0
ROE26.82%
ROA17.69%
Debt/Equity0.80
P/B Ratio9.0
Op. Cash Flow$2.1B
Free Cash Flow$1.5B
Technical Analysis
TrendBullish
RSI32.8
Support$73.35
Resistance$87.38
MA 20$81.53
MA 50$80.07
MA 200$69.52
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair Value$46.45
Target Price$87.16
Upside/Downside15.10%
GradeFair
TypeBlend
Risk Assessment
Beta0.34
Volatility24.25%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.